British patients risk missing out on cutting-edge drugs following a collapse in the number of trials

The UK initiated more trials for Covid treatments than any other European country but those for other diseases have plummeted. Industry leaders say the country must do more.

from Health News | Mail Online https://ift.tt/3ieAGp6